Endocrinology · Diabetic Complications

Diabetic Peripheral Neuropathy

USMLE2PANCE
7

Bets

The facts most likely to be tested

Press 1–5 to rate · ↑↓ to navigate

1

The most common clinical presentation is a distal symmetric polyneuropathy characterized by a stocking-glove distribution of sensory loss.

Confidence:
2

Pathophysiology involves metabolic derangement from chronic hyperglycemia leading to sorbitol accumulation and oxidative stress within peripheral nerves.

Confidence:
3

The 10-gram monofilament test is the gold standard screening tool for identifying patients at high risk for diabetic foot ulcers.

Confidence:
4

First-line pharmacologic treatment for neuropathic pain includes gabapentinoids (pregabalin or gabapentin) or SNRIs (duloxetine).

Confidence:
5

Patients often report worse symptoms at night and describe the pain as burning, tingling, or lancinating in nature.

Confidence:
6

Physical examination typically reveals diminished ankle reflexes and impaired vibratory sensation using a 128-Hz tuning fork.

Confidence:
7

Strict glycemic control is the intervention with the strongest evidence for slowing the progression of diabetic neuropathy, most robustly demonstrated in patients with Type 1 diabetes.

Confidence:

Vignette unlocked

A 62-year-old male with a 15-year history of type 2 diabetes mellitus presents for a routine follow-up. He reports a persistent burning sensation in both feet that is worse at night and interferes with his sleep. Physical examination reveals absent ankle jerks bilaterally and decreased sensation to light touch in a stocking-glove distribution. He is unable to detect a 10-gram monofilament on the plantar surfaces of his feet. His HbA1c is 8.2%.

What is the most appropriate initial pharmacologic therapy for this patient's neuropathic pain?

+Reveal answer

Duloxetine or Pregabalin

The patient presents with classic distal symmetric polyneuropathy; per clinical guidelines, SNRIs like duloxetine or gabapentinoids like pregabalin are the first-line agents for symptomatic management.

Mo

Depth

Full handout

High yield triage

Etiology / Epidemiology

Chronic hyperglycemia causes metabolic nerve damage; risk correlates with duration of diabetes and HbA1c levels.

Clinical Manifestations

Symmetric distal sensory loss in a stocking-glove pattern; loss of vibration sense is the earliest clinical sign.

Diagnosis

Diagnosis is clinical; 10-g monofilament test is the gold standard for screening for loss of protective sensation.

Treatment

Pregabalin or Duloxetine are first-line; avoid opioids due to addiction risk and lack of efficacy.

Prognosis

Major risk for diabetic foot ulcers and amputation; annual comprehensive foot exam is mandatory.

Full handout

Epidemiology & Etiology

Prevalence increases with age and duration of diabetes, affecting up to 50% of patients. Poor glycemic control is the primary modifiable risk factor. Other contributors include hypertension, dyslipidemia, and smoking.

Pertinent Anatomy

Affects the longest axons first, explaining the distal-to-proximal progression. Damage involves the peripheral nerves, specifically the small fibers (pain/temperature) and large fibers (vibration/proprioception).

Pathophysiology

Chronic hyperglycemia leads to sorbitol accumulation via the polyol pathway, causing osmotic stress. Advanced glycation end-products (AGEs) induce oxidative stress and microvascular ischemia of the vasa nervorum. This results in segmental demyelination and axonal degeneration.

Clinical Manifestations

Patients present with stocking-glove paresthesias, burning pain, or numbness. Loss of vibration sense is the most sensitive early finding. Red flags include asymmetric weakness or sudden onset, which suggest mononeuritis multiplex or radiculopathy.

Diagnosis

Diagnosis is primarily clinical based on history and physical exam. The 10-g monofilament test is the gold standard for identifying loss of protective sensation. Assess vibration sense using a 128-Hz tuning fork on the great toe.

Treatment

First-line pharmacotherapy includes Pregabalin or Duloxetine. Tricyclic antidepressants (e.g., Amitriptyline) are alternatives but carry anticholinergic side effects in the elderly. Opioids are strictly avoided for chronic neuropathic pain management.

Prognosis

Neuropathy is the leading cause of diabetic foot ulcers and non-traumatic amputations. Patients require an annual comprehensive foot exam to inspect for calluses, fissures, and deformities.

Differential Diagnosis

Vitamin B12 deficiency: presents with megaloblastic anemia and subacute combined degeneration

Alcoholic neuropathy: usually associated with nutritional deficiencies and proximal muscle wasting

Guillain-Barré syndrome: acute, ascending paralysis following a viral illness

Lumbosacral radiculopathy: dermatomal distribution rather than stocking-glove

Peripheral artery disease: pain is exertional (claudication) and relieved by rest

Diabetic Peripheral Neuropathy — USMLE2 / PANCE Board Prep | MoBets